ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE

ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE was reported 13 times

ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 1 0.0000
1 Alkylating Drug [EPC] 5 0.0000
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
3 Interleukin-23 Antagonist [EPC] 1 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
5 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
6 Corticosteroid [EPC] 3 0.0000
7 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 1 0.0000
9 Tumor Necrosis Factor Blocker [EPC] 1 0.0000